Top

Acta Neurochirurgica

Published in:

01-07-2021 | Brain Arteriovenous Malformation | Original Article - Vascular Neurosurgery - Arteriovenous malformation

Patient functional outcomes and quality of life after surgery for unruptured brain arteriovenous malformation

Authors: Joan Margaret O’Donnell, Michael Kerin Morgan, Maurizio Manuguerra, David Bervini, Nazih Assaad

Published in: Acta Neurochirurgica | Issue 7/2021

Abstract

Background

Studies have questioned the effectiveness of surgery for the management of unruptured brain arteriovenous malformation (ubAVM). Few studies have examined functional outcomes and quality of life (QOL) prior and 12 months after surgical repair of ubAVM.

Objective

This study examined the effectiveness of surgical management of ubAVM by measuring patients’ perceived QOL and their ability to perform everyday activities.

Methods

Between 2011 and 2016, patients diagnosed with an unbAVM were assessed using the Quality Metric Short Form 36 (SF36), the DriveSafe component of the off-road driver screening tool DriveSafeDriveAware (DSDA), the modified Barthel Index (mBI) and the modified Rankin Scale (mRS). Reassessments were conducted at the 6-week post-operative follow-up for surgical patients and at 12-month follow-up for surgical and conservatively managed patients.

Results

Forty-five patients enrolled in the study, of which 35 (78%) had their ubAVM surgically treated. Patients undergoing surgery had a significantly lower ubAVM Spetzler-Ponce Class (SPC). There was no significant difference 12 months after presentation in function or QOL for either the conservative or surgical group. The surgical group had significantly higher QOL of life scores from pre-surgery to 12 months post-surgery (PCS p < 0.01; MCS p = 0.02). Higher SP grade ubAVM was significantly related to poorer function in the surgical group (SP C compared with SP A; p = 0.04, mean difference − 12.4, 95%CI − 24.3 to − 0.4).

Conclusion

Function and QOL are not diminished after surgical treatment of low Spetzler-Ponce Class unruptured brain arteriovenous malformations. QOL is higher 12 months after surgery for ubAVM than for those who do not have treatment for their ubAVM.

Al-Shahi Salman R, White PM, Counsell CE, du Plessis J, van Beijnum J, Josephson CB, Wilkinson T, Wedderburn CJ, Chandy Z, St George EJ, Sellar RJ, Warlow CP (2014) Scottish Audit of Intracranial Vascular Malformations C. Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 311(16):1661–1669CrossRef

ApSimon HT, Reef H, Phadke RV, Popovic EA (2002) A population-based study of brain arteriovenous malformation: long-term treatment outcomes. Stroke 33(12):2794–2800CrossRef

Austroads (2016) Assessing fitness to drive for commercial and private vehicle drivers (2016 Edition)

Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1990) A prospective study of acute cerebrovascular disease in the community: the Oxfordshire community stroke project 1981-86. J Neurol Neurosurg Psychiatry 52:16–22CrossRef

Bervini D, Morgan MK, Ritson EA, Heller G (2014) Surgery for unruptured arteriovenous malformations of the brain is better than conservative management for selected cases: a prospective cohort study. J Neurosurg 121(4):878–890CrossRef

Davidson AS, Morgan MK (2010) How safe is arteriovenous malformation surgery? A prospective, observational study of surgery as first-line treatment for brain arteriovenous malformations. Neurosurgery 66(3):498–504CrossRef

Della Puppa A, Rustemi O, Scienza R (2015) Letter to the editor: quality of life of patients affected by unruptured brain AVMs. J Neurosurg 122(4):984–985CrossRef

Dow J (2009) Commentary: evaluation of driver fitness—the role of continuing medical education. Traffic Inj Prevent 10(4):309–311CrossRef

Gee E (2016) Reinventing Emma. Dennis Jones & Associates, Melbourne

10.

Hines A, Bundy AC (2014) Predicting driving ability using DriveSafe and DriveAware in people with cognitive impairments: a replication study. Aust Occup Ther J 61(4):224–229CrossRef

11.

Hoggarth PA (2013) Diagnosis of cognitive impairment and the assessment of driving safety in New Zealand: a survey of Canterbury GPs. N Z Med J 126(1387):87–97PubMed

12.

Kay LG, Bundy AC, Clemson LM (2009) Predicting fitness to drive in people with cognitive impairments by using DriveSafe and DriveAware. Arch Phys Med Rehabil 90(9):1514–1522CrossRef

13.

Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Maryland State Univ J 14:61–65

14.

Manuguerra M, Heller GZ, Ma J (2020) Continuous ordinal regression for analysis of visual analogue scales: the R Package ordinalCont. J Stat Softw 96:8CrossRef

15.

Marshall GA, Jonker BP, Morgan MK, Taylor AJ (2003) Prospective study of neuropsychological and psychosocial outcome following surgical excision of intracerebral arteriovenous malformations. J Clin Neurosci 10(1):42–47CrossRef

16.

Mohr JP, Overbey JR, Hartmann A, Kummer RV, Al-Shahi Salman R, Kim H, van der Worp HB, Parides MK, Stefani MA, Houdart E, Libman R, Pile-Spellman J, Harkness K, Cordonnier C, Moquete E, Biondi A, Klijn CJM, Stapf C, Moskowitz AJ (2020) ARUBA co-investigators. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol 19(7):573–581. https://doi.org/10.1016/S1474-4422(20)30181-2CrossRefPubMed

17.

Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, Al-Shahi Salman R, Vicaut E, Young WL, Houdart E, Cordonnier C, Stefani MA, Hartmann A, von Kummer R, Biondi A, Berkefeld J, Klijn CJ, Harkness K, Libman R, Barreau X, Moskowitz AJ, ARUBA co-investigators (2014) Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 383(9917):614–621CrossRef

18.

Moon K, Levitt MR, Almefty RO, Nakaji P, Albuquerque FC, Zabramski JM, Wanebo JE, McDougall CG, Spetzler RF (2015) Safety and efficacy of surgical resection of unruptured low-grade arteriovenous malformations from the modern decade. Neurosurgery 77(6):948–952CrossRef

19.

O’Donnell JM, Morgan MK, Manuguerra M (2019) Functional outcomes and quality of life after microsurgical clipping of unruptured intracranial aneurysms: a prospective cohort study. J Neurosurg 130:278–285CrossRef

20.

Patomella AH, Tham K, Johansson K, Kottorp A (2010) P-drive on-road: internal scale validity and reliability of an assessment of on-road driving performance in people with neurological disorders. Scand J Occup Ther 17(1):86–93CrossRef

21.

Pohjola A, Oulasvirta E, Roine RP, Sintonen HP, Hafez A, Koroknay-Pal P, Lehto H, Niemela M, Laakso A (2019) Long-term health-related quality of life in 262 patients with brain arteriovenous malformation. Neurology 93(14):e1374–e1384CrossRef

22.

Raghunath A, Bennett N, Arimappamagan A, Bhat DI, Srinivas D, Thennarasu K, Jamuna R, Somanna S (2016) Impact on cognitive functions following gamma knife radiosurgery for cerebral arteriovenous malformations. J Neurosci Rural Pract 7(1):28–35CrossRef

23.

Rankin J (1957) Cerebrovascular accidents in patients over the age of 60: prognosis. Scott Med J 2:200–215CrossRef

24.

Rapoport MJ, Weegar K, Kadulina Y, Bedard M, Carr D, Charlton JL, Dow J, Gillespie IA, Hawley CA, Koppel S, McCullagh S, Molnar F, Murie-Fernandez M, Naglie G, O’Neill D, Shortt S, Simpson C, Tuokko HA, Vrkljan BH, Marshall S (2015) An international study of the quality of national-level guidelines on driving with medical illness. Q J Med 108:859–969CrossRef

25.

Rohn B, Haenggi D, Etminan N, Kunz M, Turowski B, Steiger HJ (2014) Epilepsy, headache, and quality of life after resection of cerebral arteriovenous malformations. J Neurol Surg A Central Eur Neurosurg 75(4):282–288CrossRef

26.

Ross J, Al-Shahi SaR (2010) Cochrane database of systematic reviews (Online). 7:CD003436

27.

Saatci I, Geyik S, Yavuz K, Cekirge HS (2011) Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique: long-term results in 350 consecutive patients with completed endovascular treatment course. J Neurosurg 115(1):78–88CrossRef

28.

Shah S, Vanclay F, Cooper B (1989) Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol 42:703–709CrossRef

29.

Spetzler RF, Ponce FA (2011) A 3-tier classification of cerebral arteriovenous malformations. J Neurosurg 114(3):842–849CrossRef

30.

Stapf C, Moy CS, Overbey J, Moquete E, Parides M, Vicaut E, Moskowitz AJ, Mohr JP. (2014) Health-related quality of life in patients with unruptured brain avm managed with or without interventional therapy—the ARUBA trial. Stroke. Conference;45(no pagination)

31.

Thomas RH, Hughes TAT (2009) “Can I drive, doctor?” LEAN thinking may help us answer the question. Pract Neurol 9(2):71–79CrossRef

32.

Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483CrossRef

33.

Wedderburn CJ, van Beijnum J, Bhattacharya JJ, Counsell CE, Papanastassiou V, Ritchie V, Roberts RC, Sellar RJ, Warlow CP, Al-Shahi SR (2008) Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study. Lancet Neurol 7(3):223–230CrossRef

34.

Yang SY, Paek SH, Kim DG, Chung HT (2012) Quality of life after radiosurgery for cerebral arteriovenous malformation patients who present with seizure. Eur J Neurol 19(7):984–991CrossRef

Title: Patient functional outcomes and quality of life after surgery for unruptured brain arteriovenous malformation
Authors: Joan Margaret O’Donnell
Michael Kerin Morgan
Maurizio Manuguerra
David Bervini
Nazih Assaad
Publication date: 01-07-2021
Publisher: Springer Vienna
Keywords: Brain Arteriovenous Malformation
Arteriovenous Malformation
Published in: Acta Neurochirurgica / Issue 7/2021
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-021-04827-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Patient functional outcomes and quality of life after surgery for unruptured brain arteriovenous malformation

Abstract

Background

Objective

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2021

Clinical significance of vitamin D in idiopathic normal pressure hydrocephalus

Surgical Management of Symptomatic Lumbar, Sacral, and Lumbosacral Plexus Tumors: a Peripheral Nerve Unit Experience

Stereotactic posterior midline approach under direct microscopic view for biopsy of medulla oblongata tumors: technical considerations

Reducing the burden of brain tumor surgery

Awake surgery in sitting position for chronic subdural hematoma

The histological representativeness of glioblastoma tissue samples